Yichao Du

498 total citations
24 papers, 350 citations indexed

About

Yichao Du is a scholar working on Hepatology, Molecular Biology and Epidemiology. According to data from OpenAlex, Yichao Du has authored 24 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hepatology, 7 papers in Molecular Biology and 7 papers in Epidemiology. Recurrent topics in Yichao Du's work include Liver Disease Diagnosis and Treatment (5 papers), Liver physiology and pathology (4 papers) and Liver Disease and Transplantation (4 papers). Yichao Du is often cited by papers focused on Liver Disease Diagnosis and Treatment (5 papers), Liver physiology and pathology (4 papers) and Liver Disease and Transplantation (4 papers). Yichao Du collaborates with scholars based in China and United States. Yichao Du's co-authors include Peng Tan, Wenguang Fu, Baolin Qian, Xianming Xia, Yifan Chen, Meizhou Huang, Junjie Bai, Hao Shi, Fujun Lin and Lin Gao and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Experimental Cell Research and Life Sciences.

In The Last Decade

Yichao Du

21 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yichao Du China 12 161 72 61 56 50 24 350
Youngsic Jeon South Korea 16 190 1.2× 47 0.7× 33 0.5× 32 0.6× 67 1.3× 29 498
K Freese Germany 9 206 1.3× 105 1.5× 51 0.8× 46 0.8× 28 0.6× 17 373
Tingying Jiao China 11 230 1.4× 131 1.8× 59 1.0× 75 1.3× 65 1.3× 15 467
A Mahli Germany 12 193 1.2× 158 2.2× 60 1.0× 126 2.3× 31 0.6× 21 472
Mao‐xu Ge China 11 133 0.8× 157 2.2× 123 2.0× 58 1.0× 46 0.9× 15 357
Masayasu Jo Japan 9 126 0.8× 150 2.1× 97 1.6× 28 0.5× 42 0.8× 13 452
Bangxiang Xie China 10 191 1.2× 82 1.1× 30 0.5× 35 0.6× 23 0.5× 22 378
Wanfu Lin China 12 175 1.1× 44 0.6× 39 0.6× 45 0.8× 22 0.4× 24 403
Jinyi Zhong China 10 121 0.8× 31 0.4× 67 1.1× 36 0.6× 48 1.0× 28 320

Countries citing papers authored by Yichao Du

Since Specialization
Citations

This map shows the geographic impact of Yichao Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yichao Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yichao Du more than expected).

Fields of papers citing papers by Yichao Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yichao Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yichao Du. The network helps show where Yichao Du may publish in the future.

Co-authorship network of co-authors of Yichao Du

This figure shows the co-authorship network connecting the top 25 collaborators of Yichao Du. A scholar is included among the top collaborators of Yichao Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yichao Du. Yichao Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Du, Yichao, et al.. (2025). Sinomenine Ameliorates Liver Fibrosis by Blocking TGF‐β/SMAD and c‐JUN Signaling. Phytotherapy Research. 39(7). 3182–3196.
3.
4.
Bai, Junjie, et al.. (2023). Aloin Attenuates Oxidative Stress, Inflammation, and CCl4-Induced Liver Fibrosis in Mice: Possible Role of TGF-β/Smad Signaling. Journal of Agricultural and Food Chemistry. 71(49). 19475–19487. 20 indexed citations
5.
Liu, Qi, et al.. (2023). Interventional Rationalization. 5 indexed citations
6.
Bai, Junjie, Peng Tan, C. W. Liu, et al.. (2023). Zyxin promotes hepatocellular carcinoma progression via the activation of AKT/mTOR signaling pathway. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 31(5). 805–817. 3 indexed citations
7.
Du, Yichao, et al.. (2023). Efficacy and safety of surufatinib in the treatment of advanced solid tumors: a systematic evaluation and meta‑analysis. Oncology Letters. 25(6). 273–273. 3 indexed citations
8.
9.
10.
Tan, Peng, et al.. (2022). Efficacy and safety of the apolipoprotein C-III inhibitor Volanesorsen: a systematic evaluation and meta-analysis. Endocrine. 76(2). 253–262. 7 indexed citations
11.
Chen, Yifan, et al.. (2022). N-Acetyl-l-tryptophan inhibits CCl4-induced hepatic fibrogenesis via regulating TGF-β1/SMAD and Hippo/YAP1 signal. Bioorganic Chemistry. 126. 105899–105899. 5 indexed citations
12.
Bai, Junjie, Yichao Du, Peng Tan, et al.. (2022). Thiamine pretreatment improves endotoxemia-related liver injury and cholestatic complications by regulating galactose metabolism and inhibiting macrophage activation. International Immunopharmacology. 108. 108892–108892. 14 indexed citations
13.
Du, Yichao, Yifan Chen, Peng Tan, et al.. (2021). The Dietary Supplement γ‐Oryzanol Attenuates Hepatic Ischemia Reperfusion Injury via Inhibiting Endoplasmic Reticulum Stress and HMGB1/NLRP3 Inflammasome. Oxidative Medicine and Cellular Longevity. 2021(1). 4628050–4628050. 15 indexed citations
14.
Tan, Peng, et al.. (2020). Liver Metabolomics Reveals the Effect of Lactobacillus reuteri on Alcoholic Liver Disease. Frontiers in Physiology. 11. 595382–595382. 26 indexed citations
15.
Gao, Lin, Baolin Qian, Qiu Li, et al.. (2020). Hic-5 deficiency attenuates hepatic ischemia reperfusion injury through TLR4/NF-κB signaling pathways. Life Sciences. 249. 117517–117517. 6 indexed citations
16.
Tan, Peng, Yichao Du, Baolin Qian, et al.. (2019). SPOP inhibits mice pancreatic stellate cell activation by promoting FADD degradation in cerulein-induced chronic pancreatitis. Experimental Cell Research. 384(1). 111606–111606. 12 indexed citations
17.
Du, Yichao, Baolin Qian, Lin Gao, et al.. (2019). Aloin Preconditioning Attenuates Hepatic Ischemia/Reperfusion Injury via Inhibiting TLR4/MyD88/NF-κB Signal PathwayIn VivoandIn Vitro. Oxidative Medicine and Cellular Longevity. 2019. 1–14. 43 indexed citations
18.
Tan, Peng, et al.. (2019). Hic‐5 deficiency protects cerulein‐induced chronic pancreatitis via down‐regulation of the NF‐κB (p65)/IL‐6 signalling pathway. Journal of Cellular and Molecular Medicine. 24(2). 1488–1503. 11 indexed citations
19.
Tan, Peng, Yichao Du, Bing Guo, et al.. (2019). SPOP suppresses pancreatic cancer progression by promoting the degradation of NANOG. Cell Death and Disease. 10(11). 794–794. 27 indexed citations
20.
Tian, Yunhong, Jianlin Wu, Yichao Du, et al.. (2018). CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC). BMC Cancer. 18(1). 1187–1187. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Youngsic Jeon Breakdown of academic impact, for papers by K Freese Breakdown of academic impact, for papers by Tingying Jiao Breakdown of academic impact, for papers by A Mahli Breakdown of academic impact, for papers by Mao‐xu Ge Breakdown of academic impact, for papers by Masayasu Jo Breakdown of academic impact, for papers by Bangxiang Xie Breakdown of academic impact, for papers by Wanfu Lin Breakdown of academic impact, for papers by Jinyi Zhong
Rankless by CCL
2026